111 related articles for article (PubMed ID: 37644015)
1. Correction: ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.
Cui M; Chang Y; Wang J; Wu J; Li G; Tan J
Cell Death Discov; 2023 Aug; 9(1):322. PubMed ID: 37644015
[No Abstract] [Full Text] [Related]
2. ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.
Cui M; Chang Y; Wang J; Wu J; Li G; Tan J
Cell Death Discov; 2023 Feb; 9(1):41. PubMed ID: 36726012
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0042823 accelerates cancer progression
Wu T; Sun Y; Sun Z; Li S; Wang W; Yu B; Wang G
Ann Med; 2021 Dec; 53(1):960-970. PubMed ID: 34124974
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
Cui X; Yu H; Yu T; Xiao D; Wang X
Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of
Bai L; Ren Y; Cui T
J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
[TBL] [Abstract][Full Text] [Related]
7. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
8. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
Hou G; Lu Z; Bi Y; Deng J; Yang X
Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells.
Chen W; Yuan K; Tao ZZ; Xiao BK
Asian Pac J Cancer Prev; 2011; 12(7):1785-8. PubMed ID: 22126565
[TBL] [Abstract][Full Text] [Related]
10. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
11. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinicopathological significance of foxM1 gene in laryngeal squamous cell carcinoma].
Jiang L; Wang P; Chen H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(19):897-900. PubMed ID: 23285957
[TBL] [Abstract][Full Text] [Related]
13. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
14. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A.
Zhang M; Ren Z; Wang X; Liu C; Zheng Z; Zhao J; Liu H
Anal Cell Pathol (Amst); 2022; 2022():7005328. PubMed ID: 36046597
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma.
Yu B; Liang H; Ye Q; Wang Y
J Gastrointest Oncol; 2020 Oct; 11(5):1009-1023. PubMed ID: 33209494
[TBL] [Abstract][Full Text] [Related]
17. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
18. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
Zhang G; Ma J; Xiong J; Huang X; Han X; Yu X; Jiang X
Dig Dis Sci; 2021 Apr; 66(4):1097-1109. PubMed ID: 32347436
[TBL] [Abstract][Full Text] [Related]
20. Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma.
Wang L; Liu G; Bolor-Erdene E; Li Q; Mei Y; Zhou L
Aging (Albany NY); 2021 Nov; 13(21):24050-24070. PubMed ID: 34775374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
